The Beclin-1 protein is essential for the initiation of autophagy, and recent studies suggest this function may be compromised in Alzheimer's disease (AD). In addition, in vitro studies have supported a loss of function of Beclin-1 due to proteolytic modification by caspases. In the present study, we examined whether caspase-cleavage of Beclin-1 occurs in the AD brain by designing a site-directed caspase-cleavage antibody based upon a known cleavage site within the protein at position D149. We confirmed that Beclin-1 is an excellent substrate for caspase-3 and demonstrates cleavage led to the formation of a 35-kDa C-terminal fragment labeled by our novel antibody following Western blot analysis. Application of this antibody termed Beclin-1 caspase-cleavage product antibody or BeclinCCP in frontal cortex tissue sections revealed strong immunolabeling within astrocytes that localized with plaque regions and along blood vessels in all AD cases examined. In addition, weaker, more variable BeclinCCP labeling was also observed within neurofibrillary tangles that colocalized with the early tau conformational marker, MC-1 as well as the late tangle marker, PHF-1. Collectively, these data support a depletion of Beclin-1 in AD following caspasecleavage. This article is part of a Special Issue entitled "Autophagy and protein degradation in neurological diseases."
Introduction
Autophagy is an important catabolic process involving the removal of long-lived proteins, and organelles by a complex process involving numerous regulatory proteins and the formation of double-membrane vesicles known as autophagosomes, which ultimately fuse with lysosomes for degradation of contents (Rami, 2009) . Because of the central role that autophagy plays in removing unwanted proteins, this process may serve a protective role by clearing aggregated proteins in certain age-related disorders including Alzheimer's disease (AD). On the other hand, defects in autophagosome formation may lead to accumulation of toxic protein species thereby promoting neurodegeneration (Hara et al., 2006; Komatsu et al., 2006) . In AD, neurons contain more autophagosomes than do control patients and these structures tend to accumulate in dystrophic neurites (Nixon et al., 2005) . Thus, impairment of this pathway may contribute to the pathogenesis observed in AD (Yu et al., 2005) .
A key protein involved in the initiation of autophagy is the Bcl-2-interacting protein-1 (Beclin-1), the mammalian homolog of yeast Atg6 (Liang et al., 1999) . Beclin-1 is a 60-kDa coiled-coil protein that is expressed in neurons and glia (Liang et al., 1998) . A recent study demonstrated reduced levels of Beclin-1 in early AD (Pickford et al., 2008) . In the same study, the authors generated transgenic mice that were deficient in Beclin-1 and demonstrated a disruption in autophagy, increased neurodegeneration, and Aβ accumulation (Pickford et al., 2008) . These results suggest an important role for autophagy in general and Beclin-1 specifically in clearing Aβ aggregates and preserving neuronal function in AD.
Although decreased expression of the Beclin-1 protein has been demonstrated to occur in AD, the exact mechanism and cellular subtypes involved remain unknown. Because of the well-documented role of caspases in AD (Rohn and Head, 2008), we hypothesize that one mechanism leading to lower levels of Beclin-1 in AD may be proteolytic cleavage by caspases. Indeed, previous in vitro studies have demonstrated that Beclin-1 is a substrate for caspase-3 leading to inactivation of autophagy and enhanced apoptosis in Ba/F3 cell lines (Wirawan et al., 2010) . To assess whether Beclin-1 is cleaved in the AD brain, we designed a site-directed caspase-cleavage antibody to Beclin-1 based upon a known caspase-3 cleavage consensus site within Beclin-1, DQLD 149 (Luo and Rubinsztein, 2010; Wirawan et al., 2010) . In vitro, this novel antibody detected a 35-kDa C-terminal fragment of Beclin-1 following incubation with caspase-3. In addition, immunohistochemical analysis revealed the presence of caspasecleaved Beclin-1 in the AD brain that was localized primarily within Neurobiology of Disease 43 (2011) 68-78 
